These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8905244)

  • 1. Sparteine metabolism in a Nigerian population.
    Ritchie JC; Mitchell SC; Smith RL
    Drug Metabol Drug Interact; 1996; 13(2):129-35. PubMed ID: 8905244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thin-layer chromatographic screening test for polymorphic sparteine oxidation.
    Ebner T; Meese CO; Eichelbaum M
    Ther Drug Monit; 1989; 11(2):214-6. PubMed ID: 2718225
    [No Abstract]   [Full Text] [Related]  

  • 3. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers.
    Arias TD; Jorge LF; Lee D; Barrantes R; Inaba T
    Clin Pharmacol Ther; 1988 Apr; 43(4):456-65. PubMed ID: 3356089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for polymorphic oxidation of sparteine in Japanese subjects.
    Ishizaki T; Eichelbaum M; Horai Y; Hashimoto K; Chiba K; Dengler HJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):482-5. PubMed ID: 3580254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparteine oxidation polymorphism in Denmark.
    Brøsen K; Otton SV; Gram LF
    Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):357-60. PubMed ID: 4090995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparteine oxidation polymorphism in Greenlanders living in Denmark.
    Brøsen K
    Br J Clin Pharmacol; 1986 Oct; 22(4):415-9. PubMed ID: 3768256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans.
    Eichelbaum M; Woolhouse NM
    Eur J Clin Pharmacol; 1985; 28(1):79-83. PubMed ID: 3987789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease].
    Yoshino H; Hattori Y; Imai H; Narabayashi H; Chiba K
    Rinsho Shinkeigaku; 1993 Mar; 33(3):261-5. PubMed ID: 8334787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of enzyme induction on polymorphic sparteine oxidation.
    Eichelbaum M; Mineshita S; Ohnhaus EE; Zekorn C
    Br J Clin Pharmacol; 1986 Jul; 22(1):49-53. PubMed ID: 3741726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population.
    Horai Y; Taga J; Ishizaki T; Ishikawa K
    Br J Clin Pharmacol; 1990 Jan; 29(1):111-5. PubMed ID: 2297455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma.
    Paar WD; Schuhler H; Fimmers R; Dengler HJ
    Eur J Clin Pharmacol; 1989; 36(6):555-60. PubMed ID: 2590312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.
    Eichelbaum M; Spannbrucker N; Steincke B; Dengler HJ
    Eur J Clin Pharmacol; 1979 Sep; 16(3):183-7. PubMed ID: 499318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of polymorphism of sparteine oxidation in the South African Venda.
    Sommers DK; Moncrieff J; Avenant JC
    Hum Exp Toxicol; 1991 May; 10(3):175-8. PubMed ID: 1678945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    Ebner T; Meese CO; Eichelbaum M
    Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic polymorphism of sparteine metabolism.
    Eichelbaum M; Reetz KP; Schmidt EK; Zekorn C
    Xenobiotica; 1986 May; 16(5):465-81. PubMed ID: 3739368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparteine oxidation polymorphism: a family study.
    Brøsen K; Otton SV; Gram LF
    Br J Clin Pharmacol; 1986 Jun; 21(6):661-7. PubMed ID: 3741716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically determined sparteine oxidation polymorphism in a Polish population.
    Orzechowska-Juzwenko K; Pawlik J; Niewiński P; Milejski P; Dembowski J; Turek J; Goździk A; Swiebodzki L; Hora Z
    Eur J Clin Pharmacol; 1994; 46(5):481-3. PubMed ID: 7957549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.
    Arias TD; Inaba T; Cooke RG; Jorge LF
    Clin Pharmacol Ther; 1988 Sep; 44(3):343-52. PubMed ID: 3416554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of sparteine/debrisoquine oxidation: a reappraisal.
    Lennard MS
    Pharmacol Toxicol; 1990 Oct; 67(4):273-83. PubMed ID: 2077517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland.
    Clasen K; Madsen L; Brøsen K; Albøge K; Misfeldt S; Gram LF
    Clin Pharmacol Ther; 1991 Jun; 49(6):624-31. PubMed ID: 2060251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.